Document Detail


The saphenous vein as a bypass conduit: the potential role of vascular nerves in graft performance.
MedLine Citation:
PMID:  19149640     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The saphenous vein is the most commonly used conduit in patients undergoing coronary artery bypass surgery. However, a high proportion of vein grafts occlude within the first year and over 50% patients require further grafting within 10 years. Using conventional harvesting techniques the saphenous vein is damaged due to considerable surgical and mechanical trauma, a situation that affects graft patency. As a superficial vessel located in the leg, the saphenous vein in man is subjected to variations in orthostatic pressure associated with exercise and alterations in posture. These conditions require the vein's calibre to be regulated predominantly by the autonomic nervous system. While posture-induced changes occur in man, and other bipeds, such alterations in pressure may not occur or be more subtle in other species, conditions that may limit the usefulness of various experimental models. The neural control of the saphenous vein is under the influence of a plethora of neurotransmitters and neuropeptides which, apart from affecting vascular tone, possess mitogenic properties that may contribute to morphological changes caused by vascular injury. In addition to their neurotransmitter role a number of factors have a direct action on vascular smooth muscle cells that affects neural blood flow with subsequent influence on peripheral nerve conduction. Such neurovascular actions may potentially play a role in the altered vein reactivity and structure involved in graft failure. In this review we discuss the pressure changes experienced by the saphenous vein, its innervation and use as a bypass graft for revascularization of ischaemic tissue, in particular the myocardium. Also, we consider the value of various common experimental techniques for studying vasoactive and mitogenic factors and their potential role in vein graft performance.
Authors:
Michael R Dashwood; Andrzej Loesch
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current vascular pharmacology     Volume:  7     ISSN:  1570-1611     ISO Abbreviation:  Curr Vasc Pharmacol     Publication Date:  2009 Jan 
Date Detail:
Created Date:  2009-01-19     Completed Date:  2009-03-05     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101157208     Medline TA:  Curr Vasc Pharmacol     Country:  United Arab Emirates    
Other Details:
Languages:  eng     Pagination:  47-57     Citation Subset:  IM    
Affiliation:
Department of Clinical Biochemistry, Royal Free and University College Medical School, London NW3 2QG, UK. m.dashwood@medsch.ucl.ac.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Coronary Artery Bypass / methods
Graft Occlusion, Vascular / etiology*
Humans
Muscle, Smooth, Vascular / metabolism
Neuropeptides / metabolism
Neurotransmitter Agents / metabolism
Saphenous Vein / innervation,  transplantation*
Tissue and Organ Harvesting / adverse effects*,  methods
Vascular Patency
Chemical
Reg. No./Substance:
0/Neuropeptides; 0/Neurotransmitter Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Neuronal regulation of aortic valve cusps.
Next Document:  On the sympathetic innervation of the human greater saphenous vein: relevance to clinical practice.